TLDR: STANFORD, Calif.âStanford Hospital convenes patient panels to vet health AI tools before rollout, using lived experience to catch safety, bias, and usability gaps. Eric Gries, an LVAD and transplant caregiver, is one of the handpicked reviewers.
Key Takeaways:
- Stanford built an AI pipeline, then paused adoption to ask patients how tools land in real care moments.
- A âpatient panelâ at Stanford Hospital includes Eric Gries, drawing on LVAD care and transplant caregiving to evaluate new AI tools.
- Patient input surfaces âfault linesâ in trust, outcomes, and workflow, shaping which health AI gets deployed and how.
- Other panel perspectives in transplant and device experiences help pressure test tools beyond model accuracy, including consent and communication.
Tech moves fast at Stanford, but patients move the goalposts. When caregivers review AI early, adoption stops pretending âworks in theoryâ equals âworks in life.â
Tech moves fast at Stanford, but patients move the goalposts. When caregivers review AI early, adoption stops pretending âworks in theoryâ equals âworks in life.â
Q&A
What does a patient panel catch that clinical teams can miss during early health AI pilots?
It can flag clarity gaps in recommendations, misunderstandings in risk language, and workflow friction that clinicians may not notice during controlled trials.
How might patient feedback change the way hospitals measure success for health AI beyond accuracy?
Hospitals can add trust, comprehension, clinician burden, and adherence signals, because a technically correct output can still fail if people act on it differently.
What happens when AI tools are accurate but patients feel the system is intrusive or opaque?
Adoption can stall through resistance, lower engagement, and slower escalation, pushing hospitals to redesign consent materials and explainability.
Why is caregiver experience especially valuable for AI tied to chronic devices and transplant journeys?
Caregivers live with decision fatigue, symptom interpretation, and scheduling realities, so they can detect where AI advice conflicts with real routines.
Could Stanfordâs model influence how health systems regulate or audit health AI in the future?
If patient panels prove they prevent rollout harms, they may become standard audit steps alongside clinical validation and bias testing.
No comments yet. Be the first to share your thoughts!